Completed PHASE4 INTERVENTIONAL 2-arm NCT02032797

Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. (PROFETA-5)

Sponsor: Universitair Ziekenhuis Brussel

Conditions Cryopreservation Embryo Implantation Progesteron

Updated 6 times since 2017 Last updated: Sep 25, 2019 Started: Nov 30, 2012 Primary completion: Sep 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cryopreservation and Embryo Implantation and is currently completed. Universitair Ziekenhuis Brussel leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Oct 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jun 2018 — Oct 2019 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitair Ziekenhuis Brussel

Data source: Universitair Ziekenhuis Brussel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jette, Belgium